8-K filing — SANUWAVE Health, Inc. (SNWV)
Filed: 2026-09-25 AccNo: 0001628280-26-063594 Size: 133 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Stocks · News reference
What's Going on With SANUWAVE Health Stock on Friday?
NASDAQ:SNWV shares are trading down 0.5% in premarket as SANUWAVE Health beats Q2 revenue expectations, but faces financial constraints and competition.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave Health (NASDAQ: SNWV) reported Q2 2026 revenues of $9.7 million, down 3% year-over-year, with gross margins declining to 76.2% from 78.1%. The company posted an operating loss of $0.3 million versus operating income of $1.4 million in Q2 2025. While Ultramist applicator revenue grew 13%, system sales declined significantly due to CMS reimbursement pressures and a secondary market for used equipment. The company has withdrawn its 2026 guidance pending clarity on Medicare reimbursement developments.
SANUWAVE Health Q2 EPS $(0.08) Down From $(0.04) YoY, Sales $9.739M Down From $10.054M YoY
SANUWAVE Health (NASDAQ:SNWV) reported quarterly losses of $(0.08) per share. This is a 100 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $9.739 million in sales